Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercialization Highlights on Virtual Bus Tour Transcript

SA Transcripts 161.51K Followers Follow Daré Bioscience, Inc. ( DARE ) Discusses Women's Health Portfolio and Commercialization Highlights on Virtual Bus Tour August 5, 2026 10:00 AM EDT Company Participants Sabrina Johnson - CEO, President, Principal Financial Officer, Secretary & Director Conference Call Participants Justin Romanowski Presentation Justin Romanowski Hello, and thank you for joining the Daré Bioscience's Virtual Bus Tour. My name is Justin Romanowski, Managing Director of JTC IR, and I'll be the moderator for today's event. Today, the company will continue its Virtual Bus Tour series with a Southern Stop. And we are joined by Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience, who will take you through the Daré story. I will then open the event up for Q&A to take your questions. And with that, Sabrina, I'll turn it over to you to go through the story. Sabrina Johnson CEO, President, Principal Financial Officer, Secretary & Director Great. Thank you so much, and thank you, everyone, for tuning in. Obviously, the presentation contains forward-looking statements. So do look at our SEC filings for a full overview of our risk factors, including important risk factors to consider. We are focused on advancing health for women. And specifically, we're really focused on closing the gap between promising science and real-world solutions for women. I'm going to take you through a few things in our time today that really highlight some of those investment highlights and our business model. And as you'll see, as I go through the presentation, our portfolio is very much purpose-built. We're focusing on areas where the markets are large and there's clear therapeutic gaps. And as I mentioned upfront, where there's science, that if we pull it forward, can close those therapeutic gaps in care. I'm going to focus today on highlighting a couple of